Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug 29:345:e5287.
doi: 10.1136/bmj.e5287.

Kidney stones and kidney function loss: a cohort study

R Todd Alexander  1 , Brenda R Hemmelgarn, Natasha Wiebe, Aminu Bello, Catherine Morgan, Susan Samuel, Scott W Klarenbach, Gary C Curhan, Marcello Tonelli; Alberta Kidney Disease Network
Affiliations

Kidney stones and kidney function loss: a cohort study

R Todd Alexander et al. BMJ. .

Abstract

Objective: To investigate whether the presence of kidney stones increase the risk of end stage renal disease (ESRD) or other adverse renal outcomes.

Design: A registry cohort study using validated algorithms based on claims and facility utilisation data. Median follow-up of 11 years.

Setting: Alberta, Canada, between 1997 and 2009.

Participants: 3,089,194 adult patients without ESRD at baseline or a history of pyelonephritis. Of these, 1,954,836 had outpatient serum creatinine measurements and were included in analyses of chronic kidney disease and doubling of serum creatinine level.

Exposure: One or more kidney stones during follow-up.

Main outcome measures: Incident ESRD, development of stage 3b-5 chronic kidney disease (estimated glomerular filtration rate <45 mL/min/1.73 m(2)), and sustained doubling of serum creatinine concentration from baseline.

Results: 23,706 (0.8%) patients had at least one kidney stone, 5333 (0.2%) developed ESRD, 68,525 (4%) developed stage 3b-5 chronic kidney disease, and 6581 (0.3%) experienced sustained doubling of serum creatinine. Overall, one or more stone episodes during follow-up was associated with increased risk of ESRD (adjusted hazard ratio 2.16 (95% CI 1.79 to 2.62)), new stage 3b-5 chronic kidney disease (hazard ratio 1.74 (1.61 to 1.88)), and doubling of serum creatinine (hazard ratio 1.94 (1.56 to 2.43)), all compared with those without kidney stones during follow-up. The excess risk of adverse outcomes associated with at least one episode of stones seemed greater in women than in men, and in people aged <50 years than in those aged ≥ 50. However, the risks of all three adverse outcomes in those with at least one episode of stones were significantly higher than in those without stones in both sexes and age strata. The absolute increase in the rate of adverse renal outcomes associated with stones was small: the unadjusted rate of ESRD was 2.48 per million person days in people with one or more episodes of stones versus 0.52 per million person days in people without stones.

Conclusion: Even a single kidney stone episode during follow-up was associated with a significant increase in the likelihood of adverse renal outcomes including ESRD. However, the increases were small in absolute terms.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at ww.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.

Figures

None
Fig 1 Patient flow through study
None
Fig 2 Forest plot of multivariable adjusted hazard ratios for kidney stones and ESRD. Absolute rates are ESRD rates per 1 000 000 person days
See this image and copyright information in PMC

References

    1. Boddana P, Caskey F, Casula A, Ansell D. UK Renal Registry 11th annual report (December 2008). Chapter 14: UK Renal Registry and international comparisons. Nephron Clin Pract 2009;111(suppl 1):c269-76. - PubMed
    1. USRDS United States Renal Data System. Incidence and prevalence of ESRD. Am J Kidney Dis 1997;30:S40-53. - PubMed
    1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817-23. - PubMed
    1. Assimos DG, Leslie SW, Ng C, Streem SB, Hart LJ. The impact of cystinuria on renal function. J Urol 2002;168:27-30. - PubMed
    1. Jungers P, Joly D, Barbey F, Choukroun G, Daudon M. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 2004;44:799-805. - PubMed

Publication types